A pooled analysis of 3 longer-term RCTs 22,47,48 following 15,820 patients with T2DM up to 3.8 years showed a reduced risk of dementia for semaglutide and liraglutide compared with placebo 39
Semaglutide GLP-1 has gained significant attention as a powerful tool for medical weight loss, and both Dr
In clinical trials, the results were impressive: a median survival rate of 177.1 months for the early treatment Zycubo cohort compared with only 17.6 months for the untreated external cohort
No heterogeneity was presented in the included studies (I 2 = 0%, P = 0.56), and we used the fixed effects model (Fig
Hormone changes after childbirth can make it harder to manage appetite and weight
Furthermore, these medications are administered through oral, injectable, and other routes